Vitrology Secures Investment to Support Enhanced Viral Safety Testing of Human Medicines |
| 21st September, 2009 @ 12.00 am |
|
Vitrology have announced today that they secured additional investment and funding of approximately £500,000 for the support of additional service development, including the validation of enhanced nucleic acid detection systems for the viral safety testing of biopharmaceuticals, vaccines and genetic therapeutics. Full story |
Printed from http://www.sciencescotland.org/news.article.php?article_id=46 on 09/09/10 06:24:42 PM
Science Scotland is a science & technology publication brought to you by The Royal Society of Edinburgh (www.rse.org.uk).